Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNcc Regulatory News (NCC)

Share Price Information for Ncc (NCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 141.40
Bid: 141.60
Ask: 142.60
Change: 0.80 (0.57%)
Spread: 1.00 (0.706%)
Open: 139.20
High: 143.00
Low: 138.00
Prev. Close: 140.60
NCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - NCC Group Plc

16 Apr 2015 11:54

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: HARGREAVE HALE LIMITED (for Discretionary Clients)
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

NCC GROUP PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

15 APRIL 2015
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

YES

If YES, specify which: Accumuli Plc

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORDINARY 1p

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 245,800 0.1178
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

245,800 0.1178

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit
ORDINARY SALE 2,500 200.65p

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit
NONE

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit
NONE

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)
NONE

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 16 APRIL 2015
Contact name: DAVID CLUEIT

HARGREAVE HALE LTD

Telephone number: 01253 754739

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Copyright Business Wire 2015

Date   Source Headline
18th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20233:09 pmRNSBlock listing Interim Review
20th Jul 20234:51 pmRNSHolding(s) in Company
19th Jul 20234:37 pmRNSHolding(s) in Company
18th Jul 20235:14 pmRNSDirector/PDMR Shareholding
4th Jul 20231:19 pmRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSDirector/PDMR Shareholding
22nd Jun 20237:00 amRNSUnaudited Post-Close Trading and Strategy Update
8th Jun 20237:00 amRNSNotice of Trading Update
31st May 20232:32 pmRNSTotal Voting Rights
18th May 20239:57 amRNSBlock Listing Application
4th May 20231:36 pmRNSHolding(s) in Company
26th Apr 202311:48 amRNSHolding(s) in Company
25th Apr 20237:00 amRNSAppointment: Director of Strategy & Transformation
19th Apr 20233:17 pmRNSDirector/PDMR Shareholding
4th Apr 20232:24 pmRNSHolding(s) in Company
31st Mar 20235:00 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSTrading update
9th Mar 20232:54 pmRNSNCC Group announces HEAnet cyber partnership
28th Feb 20232:41 pmRNSTotal Voting Rights
15th Feb 20234:06 pmRNSHolding(s) in Company
14th Feb 20237:00 amRNSNCC Group joins Amazon Web Services Marketplace
10th Feb 202310:16 amRNSNCC Group Annual Threat Monitor Report
2nd Feb 20237:00 amRNSUnaudited Interim results period ended 30/11/2022
31st Jan 20233:00 pmRNSTotal Voting Rights
31st Jan 20233:00 pmRNSBlock listing Interim Review
30th Dec 20221:30 pmRNSTotal Voting Rights
20th Dec 20227:00 amRNSNew facilities to fund future strategy and growth
7th Dec 202211:30 amRNSBlock listing Interim Review
30th Nov 20223:30 pmRNSTotal Voting Rights
4th Nov 20225:14 pmRNSDirector/PDMR Shareholding
2nd Nov 20224:41 pmRNSDirector/PDMR Shareholding
2nd Nov 20223:50 pmRNSResult of AGM
2nd Nov 20227:00 amRNSAGM Trading Statement
1st Nov 202212:00 pmRNSDirector/PDMR Shareholding
31st Oct 20223:00 pmRNSTotal Voting Rights
31st Oct 202211:27 amRNSDirector/PDMR Shareholding
31st Oct 202211:25 amRNSDirector/PDMR Shareholding
26th Oct 202210:04 amRNSDirector/PDMR Shareholding
25th Oct 20222:35 pmRNSHolding(s) in Company
21st Oct 20229:56 amRNSDirector/PDMR Shareholding
18th Oct 20224:10 pmRNSDirector/PDMR Shareholding
12th Oct 20223:51 pmRNSDirector/PDMR Shareholding
10th Oct 20222:52 pmRNSDirector/PDMR Shareholding
10th Oct 20222:49 pmRNSDirector/PDMR Shareholding
4th Oct 20223:38 pmRNSHolding(s) in Company
30th Sep 20222:00 pmRNSTotal Voting Rights
22nd Sep 20229:00 amRNSNotice of AGM
16th Sep 20224:57 pmRNSHolding(s) in Company
16th Sep 20229:35 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.